Device and method for production and analysis of prions
10449499 ยท 2019-10-22
Assignee
Inventors
Cpc classification
B01F33/4531
PERFORMING OPERATIONS; TRANSPORTING
B01F27/117
PERFORMING OPERATIONS; TRANSPORTING
B01F31/85
PERFORMING OPERATIONS; TRANSPORTING
B01F35/413
PERFORMING OPERATIONS; TRANSPORTING
B01F2215/0431
PERFORMING OPERATIONS; TRANSPORTING
B01F33/4532
PERFORMING OPERATIONS; TRANSPORTING
B01F33/86
PERFORMING OPERATIONS; TRANSPORTING
B01F2101/44
PERFORMING OPERATIONS; TRANSPORTING
B01F31/83
PERFORMING OPERATIONS; TRANSPORTING
B01F2215/0454
PERFORMING OPERATIONS; TRANSPORTING
B01F2215/0427
PERFORMING OPERATIONS; TRANSPORTING
B01F35/221422
PERFORMING OPERATIONS; TRANSPORTING
B01F35/4121
PERFORMING OPERATIONS; TRANSPORTING
International classification
G01N33/00
PHYSICS
Abstract
The invention provides a method for producing prion protein having an aggregated conformation by contacting native conformation prion protein with aggregated conformation prion protein in a liquid preparation and subjecting this to at least one cycle or to a number of cycles of application of shear-force for fragmenting aggregates of prion protein, wherein the shear-force applied is precisely controlled. In addition to this process for amplification of aggregated state prion protein from native conformation prion protein, the invention relates to the aggregated state prion protein obtained by the amplification process, which aggregated state prion protein has one conformation, which is e.g. identical within one batch and reproducible between batches, e.g. as detectable by proteinase resistance in a Western blot.
Claims
1. A device for use as a controlled intensity shear-force generator in a process for amplification of aggregated conformation prion protein from native conformation prion protein by contacting the native conformation prion protein with the aggregated conformation prion protein in a liquid composition and subjecting the liquid composition to at least one cycle comprising generation of shear-force and a resting phase, the device containing an array of two or more devices, arranged with their longitudinal axes vertical in a temperature-controlled housing, each device in the array comprising a shear-force generator arranged to exert the shear-force to each volume element of the liquid composition containing the native conformation prion protein and the aggregated conformation prion protein, wherein a control unit controls the shear-force generator to generate the shear-force acting on each volume element of the liquid composition only at one uniform shear force intensity which is limited to an intensity range of maximally 10% of a maximum shear-force, wherein the shear-force generator comprises a rotary element arranged coaxially within a vessel and an outer surface of the rotary element is parallel to an inner wall of the vessel.
2. The device according to claim 1, wherein the control unit comprises a computer that is connected to the devices of the array and controls a rotation rate of each rotary element individually.
3. The device according to claim 1, wherein the rotary element and a coaxial section of the inner surface of the vessel are spaced and cylindrical or conical.
4. The device according to claim 3, wherein a bearing of the rotary element comprises an axle, one end of which is arranged contacting a bottom section of the inner wall and the other end of which runs in a bearing attached next to a rim of the vessel.
5. The device according to claim 1, wherein the rotation of the rotary element is controlled to within 10% of one rate.
6. The device according to claim 1, wherein the shear-force generator is controlled precisely to a range of maximally 1% of one pre-set shear-force corresponding to a rotation rate of the rotary element between 10 and 10,000 Hz.
7. The device according to claim 6, wherein the shear-force generator is controlled such that the rotation rate of the rotary element is within a range of maximally +/2 Hz.
8. A device for use as a controlled intensity shear-force generator in a process for amplification of aggregated conformation prion protein from native conformation prion protein by contacting the native conformation prion protein with the aggregated conformation prion protein in a liquid composition and subjecting the liquid composition to at least one cycle comprising generation of shear force and a resting phase, the device containing an array of two or more devices, arranged with their longitudinal axes vertical in a temperature-controlled housing, each device in the array comprising a shear-force generator arranged to exert the shear-force to each volume element of the liquid composition containing the native conformation prion protein and the aggregated conformation prion protein, wherein a control unit controls the shear-force generator to generate the shear-force acting on each volume element of the liquid composition only at one uniform shear force intensity which is limited to an intensity range of maximally 10% of a maximum shear-force, wherein the shear-force generator comprises a tube and a coaxial rotary element arranged along the longitudinal axis of the tube at a spacing from the tube, the rotary element run on bearings, and at least one exit opening arranged between the tube and the bearings, the exit opening having a cross-section of at least a cross-section between the rotary element and the tube.
9. The device according to claim 8, wherein the rotary element is fixed to one end of a coaxial axle, which axle is arranged in a first bearing formed by a poly tetrafluoro ethylene (PTFE) polymer tube arranged around a section of the axle and arranged within a sleeve, wherein the low-friction polymer tube is arranged between a shoulder of the axle and an inner shoulder of the sleeve.
10. The device according to claim 8, wherein the rotation of the rotary element is controlled to within 10% of one rate.
11. A device for use as a controlled intensity shear-force generator in a process for amplification of aggregated conformation prion protein from native conformation prion protein by contacting the native conformation prion protein with the aggregated conformation prion protein in a liquid composition and subjecting the liquid composition to at least one cycle comprising generation of shear force and a resting phase, the device containing: an array of two or more devices, arranged with their longitudinal axes vertical in a temperature-controlled housing, each device in the array comprising a shear-force generator arranged to exert the shear-force to each volume element of the liquid composition containing the native conformation prion protein and the aggregated conformation prion protein, wherein a control unit controls the shear-force generator is controlled to generate the shear-force acting on each volume element of the liquid composition only at one uniform shear force intensity which is limited to an intensity range of maximally 10% of a maximum shear-force, wherein the shear-force generator comprises a rotary element arranged coaxially within a vessel and an outer surface of the rotary element is parallel to an inner wall of the vessel; and a controlled positioning apparatus having a clamping means for holding the vessel, which positioning apparatus is adapted for positioning the vessel at a pre-determined position in relation to the shear-force generator.
12. The device according to claim 11, wherein the controlled positioning apparatus is adapted for repeatedly positioning the vessel at a pre-determined first position in relation to the shear-force generator during the generation of the shear-force and for subsequently removing the vessel from the first position and positioning the vessel at a spaced second position during a resting phase.
13. A device for use as a controlled intensity shear-force generator in a process or amplification of aggregated conformation prion protein from native conformation prion protein by contacting the native conformation prion protein with the aggregated conformation prion protein in a liquid composition and subjecting the liquid composition to at least one cycle comprising generation of shear force and a resting phase, the device containing an array of two or more devices, arranged with their longitudinal axes vertical in a temperature-controlled housing, each device in the array comprising a shear-force generator arranged to exert the shear-force to each volume element of the liquid composition containing the native conformation prion protein and the aggregated conformation prion protein, wherein the shear-force generator has a rotary element coaxially arranged in a radially spaced tube section, the radial spacing of the rotary element and the tube and the axial section in which both the rotary element and the tube extend defining a space, in which space upon rotation of the rotary element the shear-force is generated, wherein a control unit controls the shear-force generator to generate the shear-force acting on each volume element of the liquid composition only at one uniform shear force intensity which is limited to an intensity range of maximally 10% of a maximum shear-force.
14. The device according to claim 13, wherein the rotary element along its longitudinal and rotary axis has a constant outer diameter and is arranged at a constant spacing from the encircling tube section.
15. The device according to claim 13, wherein the rotation of the rotary element is controlled to within 10% of one rate.
16. The device according to claim 13, wherein the shear-force generator is controlled precisely to a range of maximally 1% of one pre-set shear-force corresponding to a rotation rate of the rotary element between 10 and 10,000 Hz.
17. The device according to claim 16, wherein the shear-force generator is controlled such that a rotation rate of the rotary element is within a range of maximally +/2 Hz.
Description
DETAILED DESCRIPTION OF THE INVENTION
(1) The invention is now described in greater detail with reference to the figures, wherein
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19) In the examples, same reference numerals refer to functionally identical elements.
(20)
(21) The surface of the rotary element 1 can be parallel to the wall of the vessel 5, forming a homogenous shear force for a cylindrical rotary element in a cylindrical vessel 5. In the case of a conical vessel 5, a rotary element that is conical for being in parallel to the vessel 5 will generate a shear force gradient in accordance with the change in radius. Generally, if the shear force gradient caused by the angle of the conical shape of the vessel and the parallel conical shape of the rotary element exceeds the narrow range of one shear force intensity, it is preferred that the angle of the cone of the rotary element is smaller to the axle than the cone of the inner vessel wall to its longitudinal axis, preferably such that the spacing between the vessel and the rotary element increases with increasing radius of the rotary element and vessel, respectively.
(22) This embodiment has the advantage that it can be realized using a commercial vessel 5, e.g. an Eppendorf vial, into which the rotary element 1 is positioned and held by a second bearing 4 which is provided by a plate serving as a holder 7 arranged in a recess of a lid 8.
(23) Rotation of the rotary element 1 within vessel 5 at a closely controlled rotation frequency, i.e. at a narrow range about one pre-set rotation frequency generates a shear force of a narrow range about one pre-set shear force between the rotary element 1 and the vessel 5.
(24)
(25) A first element of a coupling 10, e.g. a permanent magnet, is fixed to the axle 2. Preferably, the device is encased within a sealable housing 30, and the second element of the coupling 12 is arranged outside the housing 30, allowing the drive 11 coupled to the second element of the coupling 12 to drive the first element of a coupling 10, and hence the axle 2 which bears the rotary element 1.
(26) The embodiment of the device depicted in
(27)
(28)
EXAMPLE 1
Device for Generating Controlled Shear-force of a Limited Intensity Range
(29) As an example, a device as schematically shown in
(30) The bearing was as shown in
(31) For forming an array of the devices, two or more devices, preferably 14 or 21 were arranged with their longitudinal axes vertically in a temperature-controlled housing. All devices of the array were controlled by one computer.
(32) The shear rate was controlled by a potentiometer and multimeter, regulating the rates of rotation between 20 to 1300 Hz with a variation of 5 Hz, preferably 2 Hz, and more preferably of 1 Hz.
(33) It was found that these devices could be run for 136 cycles of 60 s rotation at 20 to 1300 Hz and 540 s resting phase without rotation with an accuracy of rotation of 1 Hz for treatment of aqueous liquid compositions at 5 C. to 40 C. in one experiment, and these devices could be used for up to 10 experiments. The bearing was essentially stable, maintained a low-resistance movement of the rotary element which is essential for reproducibility of rotation rates, and did not show excessive wear.
(34) As a comparative bearing, a rolled-up sheet of PTFE foil was arranged between the rotary element and the tube. After rotating for 10 cycles of 60 s with 540 s resting phase, the rolled-up sheet forming the bearing had run hot and was partially destroyed, whereas a bearing consisting of a PTFE tube arranged between the rotary element and a tube section could run for at least 5 min at the same speed, and could be used to a total service life of at least 60 min up to 24 h.
(35) For comparison to a device of the invention having two exit openings with a total cross-section of the cross-section that is limited by the rotary element and the tube section encircling it, a device was used, wherein the exit opening was one boring of 1.5 mm diameter, i.e. a cross-section of 1.767 mm.sup.2. It was found that this smaller exit opening resulted in irreproducible products from liquid compositions containing native conformation prion protein with aggregated conformation prion protein. Currently, it is assumed that the smaller exit opening results in shear forces which are generated in addition to the shear forces generated by the rotary element. Further, it was observed that in these devices, liquid composition was drawn into the bearing, allowing the bearing to exert additional shear forces onto the liquid.
EXAMPLE 2
Production of Aggregated Conformation Prion Protein
(36) As a first experiment, the starting liquid composition contained 5% vol/vol of the Protease K-resistant prion protein Sc237 BH, representing an aggregated conformation prion protein which is known to induce amplification of the aggregated conformation in the native conformation shNBH, was admixed with a 10% wt/vol preparation of hamster prion protein shNBH (Syrian hamster normal brain homogenate) having the native conformation, which was produced by homogenization of brain tissue detergent containing aqueous buffer solutions. From this stock, aliquots were each subjected to different shear force intensities using an array of the devices of Example 1 at cycles of 60 s shear force and 9 min resting phase without agitation for a total of 46 h in a thermostat at 37 C. to a shear force by rotation rates as indicated in
(37) No deterioration of the precision of the shear force, i.e. no deviation of the control of rate of rotation was observed over the number cycles, indicating the reliability of the device.
(38) For analysis of the amplification reactions, aliquots from each reaction were taken and digested with Proteinase K added to 50 g/ml or 10 g/ml, respectively. Samples were separated by SDS PAGE, detection was in a Western blot using anti-PrP antibody and Western Pico ECL solution (Pierce) for signal generation. The results are shown in
(39) The Western blots show that the amount of Proteinase K resistant prion protein generated by amplification differs in dependence on shear force intensity, as indicated by the rates of rotation. Further, the comparison of samples generated at one shear force intensity but digested with different concentrations of Proteinase K indicates that the change in signal intensity differs between samples according to the shear force intensity. A quantitative analysis is shown in
(40) This indicates that there is an optimum shear force intensity for amplification of the aggregated conformation of a prion protein.
(41) A further effect of the different shear force intensities applied during amplification can be seen for the different Proteinase K concentrations, which show that the relative resistance against proteolysis differs between shear force intensities. This result indicates that the different shear force intensities result in different aggregated conformations of one prion protein during amplification.
(42) As a second experiment, 0.001 vol/vol of 10% wt/vol aggregated conformation Sc237 (hamster) prion protein was added to native conformation prion protein hamster PrP (amino acids 23-230) at 100 g/ml to form a liquid composition for amplification using a total volume of 10 ml per reaction. For the process, 144 cycles of 60 s shear force and 9 min resting phase without agitation were performed at 37 C. An array of 7 devices as above was used, with the rotation rates controlled to 109 rpm to 406 Hz, controlled to a range of 1 Hz. Aliquots of samples were digested with 0.25 g/ml Proteinase K at 37 C. for 30 min and analysed by SDS-PAGE and Western blotting. The result is shown in
(43)
EXAMPLE 3
Analysis of Interaction of Test Compound on Amplification
(44) Analysis of interaction of test compounds with prion protein that influences the amplification of aggregated conformation prion protein from native conformation prion protein was performed using aggregated prion protein produced according to Example 2 at one shear force intensity. A test compound was added at 6 g/ml to 600 g/ml to a liquid composition of 5% vol/vol Sc237 BH in 10% wt/vol native conformation hamster prion protein shNBH. Aliquots of the composition were subjected to 144 cycles of 60 s shear force and 9 min resting phase without agitation at 37 C. An array of 12 devices as above was used, with the rotation rates controlled to 1000 rpm to 16000 rpm, controlled to a range of 1 Hz. Aliquots of samples were digested with 5 to 50 g/ml Proteinase K at 37 C. for 30 min and analysed by SDS-PAGE and Western blotting.
EXAMPLE 4
Production of Distinct Aggregated Conformation Prion Protein Using Different Shear-force Intensities
(45) Using an admixture of aggregated conformation Sc237 prion protein and a 10% preparation of normal hamster brain extract, aliquots were subjected to different shear-forces using the array of devices of Example 1. Shear-forces were generated at the rotation speeds indicated in Hz, samples were taken at 0, 1, 3, 6, 12, and 22 h during amplification (cycles of 5 s rotation, 5 min resting phase) as indicated.
(46)
(47) These results show that the method produces a homogenous aggregated conformation prion protein at specific distinct shear-forces, because the efficacy and rate of the amplification are dependent on the intensity of the shear-force applied.
EXAMPLE 5
Production of Homogenous Aggregated Conformation Prion Protein Using One Shear-force Intensity
(48) For producing a preparation of aggregated conformation prion protein, Sc237 was admixed at 1/2500 with 50 g/mL recombinantly produced and purified native conformation prion protein in a total reaction volume of 10.0 mL. For generating the shear-force, a rotating shear-force generator as described in Example 1 was rotated at 756 Hz at +/1 Hz for 60 s with 540 s resting phase for 136 cycles. The comparative spontaneous amplification product was generated under the same processing conditions but with no aggregated prion protein added to the initial reaction, i.e. without Sc237 as a seeding agglomerated conformation prion protein.
(49)
(50) The produced aggregated conformation product was pelleted by centrifugation, yielding a total of 6 mg proteinase K-resistant protein when isolated. This protein, which following the production process is unperturbed, was used for solid-state .sup.13C-NMR.
(51) As a comparative sample, the product of spontaneous amplification (without initial aggregated prion protein) was used similarly for .sup.13C-NMR.
(52) The CP-MAS NMR: .sup.13C, .sup.13C correlation is shown in
EXAMPLE 6
Analysis of a Mammalian Sample for Presence of Aggregated Conformation Prion Protein
(53) Analysis of the presence of aggregated conformation, i.e. disease-associated prion protein in a mammal was done using serial dilutions of 5% vol/vol Sc237 BH . The sample dilution was added to 10% wt/vol native conformation hamster prion protein, e.g. shNBH. Aliquots of the composition were subjected to 144 cycles of 60 s shear force and 9 min resting phase without agitation at 37 C. An array of 12 devices as above was used, with the rotation rates controlled to 1000 rpm to 16000 rpm, controlled to a range of 1 Hz. Aliquots of samples were digested with 5 to 50 g/ml Proteinase K at 37 C. for 30 min and analysed by SDS-PAGE and Western blotting.
EXAMPLE 6
Device for Controlled Shear-force Generation Using Sonotrode
(54) This Example shows a currently preferred embodiment of a device for application of controlled shear-force to the inner volume of reaction vessels using ultrasound.
(55) As shown in
(56) The arrangement of holder 51 in a guiding bore 53 allows to accurately and repeatedly position the vessel 31 in relation to the shear-force generator, in this embodiment represented by the sonotrode 41.
(57)
REFERENCE NUMERAL LIST
(58) 1 rotary element 2 axle 3 first bearing 4 second bearing 5 vessel 6 boring 7 holder 8 lid 10 first element of coupling 11 drive 12 second element of coupling 13 control unit 14 sensor 20 tube 21 exit opening 22 polymer tube 23 shoulder 24 sleeve 25 inner shoulder 30 housing 31 vessel 40 sonotrode surface, sonicator surface 41 sonotrode, sonicator 42 side wall 43 spacer 44 filling pipe 45 exit for transfer liquid 46 drive and converter unit 50 clamping means 51 holder 52 abutment face 53 threaded bore 54 cover